search
MARILYNN MARCHIONE
Rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the US, March 2020. (Gilead Sciences via AP)
May 2, 2020, 12:58 am
Trump announces emergency approval for 1st drug shown to help virus recovery
In preliminary US trial, Gilead Science’s remdesivir shortens recovery time by 4 days; cleared for use for hospitalized patients with ‘severe disease’
By MATTHEW PERRONE and MARILYNN MARCHIONE
A vial of Gilead Sciences' remdesivir drug is seen during a press conference about the start of a study with drug in particularly ill coronavirus patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany on April 8, 2020. (Ulrich Perrey/Pool/AFP)
April 29, 2020, 7:35 pm
Experimental drug declared by US as first effective treatment against COVID-19
Dr. Anthony Fauci says trial on patients shows GIlead Sciences remdesivir ‘can block this virus,’ American government to work to boost availability of the antiviral medication
By Martin Crutsinger, MARILYNN MARCHIONE and Anne D'Innocenzio
In this April 10, 2020, file photo, amid coronavirus concerns, a US healthcare worker takes the temperature of a visitor to Essentia Health who was crossing over a skywalk bridge from the adjoining parking deck, in Duluth, Minnesota. (Alex Kormann/Star Tribune via AP, File)
April 20, 2020, 9:32 am
Uncertainty around asymptomatic virus cases sparks hopes and fears
Much research, better testing required to know extent of under-the-radar cases; it means more people around us may be infected, but shortens path to supposed herd immunity
By MARILYNN MARCHIONE
In this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in Philadelphia. (Penn Medicine via AP)
November 6, 2019, 6:36 pm
In first, US doctors try CRISPR gene editing for cancer treatment
Procedure that bolsters patients’ immune systems by helping cells better identify and fight against cancer has so far yielded encouraging results
By MARILYNN MARCHIONE
In this December 15, 2018 photo, Supreme Court Justice Ruth Bader Ginsburg appears at an event organized by the Museum of the City of New York with WNET-TV held at the New York Academy of Medicine in New York. (AP Photo/Rebecca Gibian)
August 23, 2019, 9:59 pm
Supreme Court: Ruth Bader Ginsburg treated for tumor on pancreas
Officials say judge completed radiation therapy, no evidence of disease remaining in her 4th bout with cancer since she joined the court in 1993
By Jessica Gresko and MARILYNN MARCHIONE
In this Oct. 9, 2018 photo, an embryo receives a small dose of Cas9 protein and PCSK9 sgRNA in a sperm injection microscope in a laboratory in Shenzhen in southern China's Guangdong province. (AP/Mark Schiefelbein)
November 26, 2018, 5:42 am
Chinese scientist claims he created first-ever gene edited babies
Some protest crossing of ethical boundaries after He Jiankui says he used CRISPR technology to make HIV-resistant twin girls, in groundbreaking move that could rewrite biology
By MARILYNN MARCHIONE
Illustrative photo of an obese woman on a scale. (Photo via Shutterstock)
August 20, 2015, 2:41 am
Scientists find how obesity gene works, a clue to treatment
Genetics specialist at Beth Israel Deaconess Medical Center says new experiments reveal a mechanism previously unsuspected
By MARILYNN MARCHIONE
Peanut-based Israeli snack Bamba
February 24, 2015, 1:56 am
Israeli kids help prove early exposure to peanuts prevents allergies
Counter-intuitive, ‘transformative’ research compares Bamba-noshing youngsters with London Jewish children whose parents kept them away from such foods
By MARILYNN MARCHIONE
Working on breast cancer research at the Ben-Porath laboratory, Hadassah Hospital, Jerusalem. (Keren Freeman/Flash90)
August 9, 2014, 2:04 am
Study ties new gene to major breast cancer risk
Presence of PALB2 mutations make deadly disease nine times more likely, researchers find
By MARILYNN MARCHIONE
Load More
Now, more than ever, is the time to support quality journalism
A message from the Editor
David Horovitz

Our team is covering the coronavirus crisis in Israel and the Jewish world around the clock - because we know how essential trustworthy information is to you right now. If you appreciate the fast, fair and free journalism of Times of Israel, then now is the time to support our work - and receive an AD-FREE experience.

Read more

For as little as $6 a month, you can help support our independent journalism — and enjoy an AD-FREE experience, as well as special content and benefits as a Times of Israel Community member.

The Times of Israel covers one of the most complicated and contentious parts of the world. Determined to keep readers fully informed and enable them to form their own opinions, The Times of Israel has established itself as the leading source of independent and fair-minded journalism on Israel, the region and the Jewish world.

We've achieved this by investing ever-greater resources in our journalism while keeping all of the content on our site free.

Unlike many other news sites, we have not put up a paywall. But we would like to invite readers who can afford to do so, and for whom The Times of Israel has become important, to help support our journalism by joining The Times of Israel Community.

So join now - and for as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE on desktop and mobile, as well as special benefits and status as a Times of Israel Community member.

* The AD-FREE experience is available for signed-in Community members, on The Times of Israel website on desktop and mobile, and in the iOS and Android apps. Minimal advertising will continue to display on The Times of Israel newsletters.

Join the times of israel community Join our community Already a member? Sign in to stop seeing this